Robotic surgery is on the rise and increasingly being deployed for less invasive and more precise surgery. HBI speaks to a consultant (and robot enthusiast) to find out more.
HBI talks to Biju Mohandas, partner and global co-leader for healthcare investments at global impact investor LeapFrog Investments, about investment strategy, increased localisation of supply chains, and the opportunities and the risks of artificial intelligence.
Global asset manager AXA's investment arm, AXA IM Alts, has entered the Italian market with the forward-purchase of a six-asset portfolio from real estate management company Namira.
The private healthcare markets in major Indian and middle eastern cities are on the brink of becoming mature according to a consulting source, and this will require operators and investors to take a different approach.
As public health experts, governments, and the WHO ask questions about the risks posed by AI, HBI speaks to two market experts. Should we be concerned or optimistic about its increasing use, specifically in health care?
Spanish insurer Sanitas and Italian insurer Generali are facing court action over a patient-sharing partnership affecting Spanish providers, which allegedly violates Spain’s competition rules.
The growing self-pay middle market in the UK is set to boom off the back of continuing NHS struggles, and patients' increasing willingness to pay for affordable alternatives. HBI speaks to multiple sources and hears groups accustomed to NHF tariff work could benefit most.
Plans to ban indirect private equity ownership of MVZ outpatient facilities in Germany would have a huge impact on radiotherapy according to an operator source and panellist at HBI 2023.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
